Advanced search
1 file | 120.06 MB Add to list

Finding the 'key' in leukemia : PIM1 inhibition as a novel therapy in T-cell acute lymphoblastic leukemia

Renate De Smedt (UGent)
(2020)
Author
Promoter
(UGent) and (UGent)
Organization

Downloads

  • (...).pdf
    • full text (Published version)
    • |
    • UGent only (changes to open access on 2023-11-24)
    • |
    • PDF
    • |
    • 120.06 MB

Citation

Please use this url to cite or link to this publication:

MLA
De Smedt, Renate. Finding the “key” in Leukemia : PIM1 Inhibition as a Novel Therapy in T-Cell Acute Lymphoblastic Leukemia. Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen, 2020.
APA
De Smedt, R. (2020). Finding the “key” in leukemia : PIM1 inhibition as a novel therapy in T-cell acute lymphoblastic leukemia. Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen.
Chicago author-date
De Smedt, Renate. 2020. “Finding the ‘key’ in Leukemia : PIM1 Inhibition as a Novel Therapy in T-Cell Acute Lymphoblastic Leukemia.” Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen.
Chicago author-date (all authors)
De Smedt, Renate. 2020. “Finding the ‘key’ in Leukemia : PIM1 Inhibition as a Novel Therapy in T-Cell Acute Lymphoblastic Leukemia.” Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen.
Vancouver
1.
De Smedt R. Finding the “key” in leukemia : PIM1 inhibition as a novel therapy in T-cell acute lymphoblastic leukemia. Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen; 2020.
IEEE
[1]
R. De Smedt, “Finding the ‘key’ in leukemia : PIM1 inhibition as a novel therapy in T-cell acute lymphoblastic leukemia,” Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen, 2020.
@phdthesis{8682988,
  author       = {{De Smedt, Renate}},
  language     = {{eng}},
  pages        = {{XV, 206}},
  publisher    = {{Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen}},
  school       = {{Ghent University}},
  title        = {{Finding the 'key' in leukemia : PIM1 inhibition as a novel therapy in T-cell acute lymphoblastic leukemia}},
  year         = {{2020}},
}